DXCM - DexCom Non-GAAP EPS of $0.50 beats by $0.17 revenue of $975M beats by $37.38M
2023-10-26 16:04:37 ET
More on DexCom
- Why DexCom May Be Up To 40% Undervalued
- Dexcom Denies Weight Loss Drug Threat To CGM Sales - I'd Be A Little Concerned
- DexCom: I Expect Growth To Continue At This Strong Rate, Buy
- DexCom Q3 2023 Earnings Preview
- Boston Sci, Stryker, Dexcom, Shockwave are BoA's top medtech picks
For further details see:
DexCom Non-GAAP EPS of $0.50 beats by $0.17, revenue of $975M beats by $37.38M